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Even though the endocrine-disrupting potential of perfluorooctanoic acid (PFOA) is well known, the mechanisms underlying 
its cellular and epigenetic toxicity at the critical stage of hypothalamic development are poorly understood. This is why 
we studied its effects on the embryonic mouse hypothalamic cell line N46 (mHypoE-N46) with a hope to shed more light 
on the mechanisms through which PFOA causes embryonic hypothalamic cell damage. To do that, we studied cell viability, 
global DNA methylation, and gene expression in cells exposed to PFOA. As the PFOA dose increased, cell viability 
decreased, while global DNA methylation increased. PFOA also significantly altered the expression of genes related to 
the apoptosis and cell cycle, neurotrophic genes, and the Tet, Dnmt, and Mecp2 genes. Our findings suggest that exposure 
to PFOA affects cell survival through the reprogramming of embryonic hypothalamic DNA methylation patterns and 
altering cell homeostasis genes. DNA methylation and changes in the Mecp2 gene expression induced by PFOA also 
imply wider ramifications, as they alter genes of other major mechanisms of the embryonic hypothalamus. Our study 
may therefore serve as a good starting point for further research into the mechanisms of PFOA effect of hypothalamic 
development.
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Perfluorooctanoic acid (PFOA) is a synthetic surfactant 
used in various industrial and consumer water- and oil-
resistant products with the annual production of several 
hundred metric tonnes since the 1950s, which makes it one 
of the most abundantly produced endocrine-disrupting 
chemicals (EDCs) worldwide (1). Its strong carbon-fluorine 
bond renders it highly stable and prone to bioaccumulation 
in the environment (2). It can easily be found in water, food, 
house dust, stain-resistant carpets, cookware coatings, and 
industrial waste (3–6). This indicates a high risk of 
exposure, which has been confirmed by its discovery in 
human blood, breast milk, and umbilical cord serum (7–11). 
In addition, with its average half-life in humans of 2.4 years 
(12), PFOA has a potential of high bioaccumulation.
Exposure to EDCs such as PFOA during early 
development can have lifelong detrimental effects on 
metabolic homeostasis and endocrine physiology (13, 14). 
However, while studies demonstrate that development of 
the embryonic hypothalamus can be disrupted by PFOA, 
the underlying molecular mechanisms for the metabolic 
toxicity of PFOA are not yet clear. These involve epigenetic 
covalent modifications of histone tails (15, 16), small non-
coding RNAs that regulate gene expression (17), and DNA 
methylation (18–20). Modifications in DNA methylation 
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patterns lead to developmental reprogramming, and these 
epigenetic changes can be inherited through cell division 
(21). In addition, transgenerational exposure to EDCs can 
affect embryonic cell development through genomic 
imprinting (22). Previous research has shown that PFOA 
exposure induces changes in global DNA methylation in 
human umbilical cord serum (23), mouse embryonic 
fibroblasts (24), and human hepatocellular carcinoma cells 
(25), but there have been no studies on the effects of PFOA 
on global DNA methylation in mouse embryonic 
hypothalamus cells.
To fill this gap, our study focused on epigenetic toxicity 
and cytotoxicity of PFOA in mHypoE-N46 cells and its 
effects on gene expression and how it affects apoptosis, cell 
cycle, proliferation, and neurotrophic genes. In addition, it 
looked into its effects on gene modifications of ten-eleven 
translocation methylcytosine dioxygenases (Tets), DNA 
methyltransferases (Dnmts) and methyl-CpG binding 
protein 2 (Mecp2s).
MATERIALS AND METHODS
Cell culture and reagents
The mHypoE-N46 (Cellutions Biosystems, Burlington, 
Canada) cell line, derived from the mouse embryonic 
hypothalamus was immortalised by retroviral transfer of 
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SV40 T-antigen into embryonic mouse hypothalamic 
primary cell cultures (days 15, 17, and 18) (26). The cells 
were cultured as a monolayer in Dulbecco’s modified Eagle 
medium (DMEM) with 25 mmol/L glucose (Sigma-Aldrich, 
St. Louis, MO, USA) supplemented with 2 % foetal bovine 
serum (FBS, Gibco, Carlsbad, CA, USA) and 1 % penicillin/
streptomycin (Welgene, Daegu, Korea). The cells were 
incubated at 37 °C in 5 % CO2.
PFOA (Sigma-Aldrich) at final concentrations with a 
10-fold difference from 0.25 to 250 µmol/L was dissolved 
in dimethyl sulphoxide (final concentration 0.1 %; Sigma-
Aldrich). Dimethyl sulphoxide (0.1 %) was not toxic to the 
mHypoE-N46 cells and had no effect on cell survival or 
ability to divide (data not shown). To eliminate the effects 
of steroids contained in DMEM and FBS, PFOA treatment 
was performed in phenol red-free DMEM with 25 mmol/L 
glucose (Gibco), supplemented with 1 % charcoal-stripped 
FBS and 1 % penicillin/streptomycin.
Assessment of cell viability
The cells were seeded at 5x103 cells per well in 96-well 
plates with 200 µL of fresh complete medium and incubated 
at 37 °C in 5 % CO2 for 24 h. Cell culture medium (200 µL) 
was then replaced, and PFOA (at final concentrations of 0, 
0.25, 2.5, 25, and 250 µmol/L) was added and incubated 
for 24 or 48 h. The CellTiter 96® non-radioactive cell 
proliferation assay kit (Promega, Madison, WI, USA) was 
used according to the manufacturer’s protocol. The 
absorbance was read at 570 nm using an enzyme-linked 
immunosorbent assay (ELISA) microplate reader 
(Molecular Devices, San Jose, CA, USA). The measured 
optical density values were normalised and cell viability 
analysed with the GraphPad Prism Software 7.0 (GraphPad 
Software, San Diego, CA, USA).
RNA isolation and quantitative real-time PCR
Neurons were harvested and total RNA extracted using 
the TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Total 
RNA purity and concentration were quantified with the 
Nanodrop 2000 spectrophotometer (Thermo Fisher 
Scientific, Waltham, MA, USA). Quantitative real-time 
PCR was performed using the iTaqTM Universal SYBR® 
Green One-Step kit (Bio-Rad, Foster, CA, USA) with gene-
specific primers (Table 1). Data were analysed using the 
2-ΔΔCT method and transcript levels were normalised to those 
of the standardisation gene (β-actin).
Global DNA methylation assay
Genomic DNA from mHypoE-N46 was extracted 
immediately after PFOA treatment using the G-spinTM Total 
DNA Extraction Kit (iNtRON Biotechnology, Seongnam, 
Korea). Total DNA quantity and quality were tested with 
the Nanodrop 2000 spectrophotometer (Thermo Fisher 
Scientific). The whole-genome DNA methylation profile 
was determined using the EpiGentek MethylFlash Global 
DNA Methylation (5-mC) ELISA Easy Kit (Epigentek, 
Farmingdale, NY, USA) following the manufacturer’s 
protocols.
Statistical analysis
Results are presented as mean ± SEM (standard error 
of the mean) and analysed with the GraphPad Prism 
Software 7.0. Statistical significance at p<0.05 was 
determined with one-way ANOVA, followed by a 
Bonferroni post hoc test. For the calculation of the half 
maximal inhibitory concentration (IC50), we relied on the 




The MTT analysis showed a drop in cell viability in a 
dose-dependent manner in both 24 and 48-hour PFOA 
treatment (Figure 1). No statistically significant differences 
were found between the PFOA concentrations of 
0.25 µmol/L and 2.5 µmol/L, but they started to show with 
25 µmol/L (p<0.01) and 250 µmol/L (p<0.001). As 48-hour 
PFOA treatment showed little difference from the 24-hour 
treatment, all subsequent experiments were done in cells 
cultured with PFOA for 24 h. IC50 for 24-hour exposure to 
PFOA was 27.5 µmol/L. Gene expression experiments were 
therefore performed on cells treated with 2.5 µmol/L and 
Figure 1 Cell viability of mHypoE-N46 cells following PFOA treatment for (A) 24 h and (B) 48 h (MTT assay). Data are shown as 
mean ± standard error of triplicate measurements. ** p<0.01 and *** p<0.001 compared to control
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Table 1 List of primer sequences for quantitative real-time polymerase chain reaction

































































































25 µmol/L of PFOA, whose viability was higher than the 
IC50.
Effect of PFOA on apoptosis-, cell cycle-, and 
proliferation-related genes
Because of the previously reported effects of PFOA on 
cell cycle and proliferation (25, 28–30) and the strong effect 
on cell viability found in this study, we decided to continue 
by testing several genes related to apoptosis, cell cycle, and 
proliferation.
Figure 2A shows the expression levels of the apoptotic 
genes Bax, Casp3, and Trp73. The expression of the Bax 
gene, which acts as a pro-apoptotic regulator, increased 
significantly (p<0.001) upon PFOA exposure in a dose-
dependent manner, while the Casp3 gene expression in 
apoptotic cells significantly decreased at 2.5 µmol/L 
(p<0.01) and 25 µmol/L (p<0.05). The mRNA level of the 
Trp73 gene, which encodes for the p73 protein involved in 
cell-cycle regulation and induction of apoptosis, significantly 
decreased after exposure to 2.5 µmol/L (p<0.05) and 
25 µmol/L (p<0.01) of PFOA.
Figure 2B shows the expression patterns of three cell 
cycle-related genes, Ccna2, Ccnb1, and Ccne1. PFOA had 
no significant effect on Ccna2, but the expression of Ccnb1, 
which encodes for G2/mitotic-specific cyclin-B1, increased 
significantly in dose-dependent manner upon exposure to 
both 2.5 µmol/L (p<0.01) and 25 µmol/L (p<0.001) of 
PFOA. Ccne1 gene expression, on the other hand, was 
downregulated at both PFOA concentrations (p<0.01).
Figure 2C shows the expression levels of Cdkn1a, Cdk4, 
Rps6, and Kit1, which are genes related to cell proliferation. 
The expression of the cyclin-dependent kinase (CDK) 
inhibitor 1-encoding Cdkn1a significantly increased in a 
dose-dependent manner (p<0.05 at 2.5 µmol/L and p<0.001 
at 25 µmol/L), but other proliferation gene expressions were 
not significantly affected.
Effect of PFOA on nerve growth factor-related genes
In the nerve growth factor – neurotrophic tyrosine 
kinase receptor type 1 (NGF-NTRK1) neurotrophin system, 
the gene expression level of the ligand Ngf significantly 
increased (p<0.05) with exposure to 25 µmol/L of PFOA, 
unlike the gene expression of receptor Ntrk1 (Figure 3A).
In the BDNF-NTRK2 neurotrophin system, 25 µmol/L 
of PFOA significantly (p<0.01) increased the expression of 
the ligand Bdnf gene, while both concentrations significantly 
increased the expression of Ntrk2, a high-affinity catalytic 
receptor for several neurotrophins and BDNF (p<0.001) 
(Figure 3B).
Epigenetic toxicity of PFOA
As PFOA showed dose-dependent effects on some 
genes, we decided to assess global DNA methylation to 
better understand its effect on genome-wide gene 
expression. Genome-wide 5-methylcytosine content 
showed a significant dose-dependent increase compared to 
control at both PFOA concentrations (p<0.01 at 2.5 µmol/L 
and p<0.001 at 25 µmol/L) (Figure 4A).
To better understand the mechanism of how methylation 
levels change, we also analysed relative gene expression 
of Tet1, Tet2, Tet3, Dnmt1, Dnmt3a, and Dnmt3b. Tet1 and 
Tet3 increased significantly with both PFOA concentrations 
(p<0.001), whereas the mRNA expression of Tet2 
significantly decreased at PFOA concentration of 
2.5 µmol/L (p<0.05) (Figure 4B). The expression of Dnmt1 
(p<0.05), Dnmt3a, and Dnmt3b (p<0.001) significantly 
decreased at 25 µmol/L of PFOA, while the Dnmt3b gene 
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Figure 2 Expression of (A) apoptosis-related genes, (B) cell cycle-related genes, and (C) cell proliferation-related genes after 24 h of 
exposure to PFOA (qPCR). Data are shown as mean ± standard error of three independent measurements. * p<0.05, ** p<0.01, and 
*** p<0.001 compared to control
186 Kim H, et al. Epigenetic toxicity and cytotoxicity of perfluorooctanoic acid and its effects on gene expression in embryonic mouse hypothalamus cells Arh Hig Rada Toksikol 2021;72:182-190
expression also significantly decreased at 2.5 µmol/L 
(p<0.01) (Figure 4C). Finally, in order to investigate the 
effect of PFOA on CpG-DNA-mediated gene transcription 
and the involvement of methyl-CpG binding protein, we 
analysed the changes in gene expression of Mecp2 isoforms 
e1 and e2, which are important readers of DNA methylation. 
The expression of both isoforms, significantly decreased at 
2.5 µmol/L (p<0.01 and p<0.05, respectively; Figure 4D).
DISCUSSION
To determine the effects of PFOA on embryonic 
hypothalamic cell metabolism, this study evaluated the 
expression of apoptosis, cell cycle, and cell proliferation 
genes that play an important role in the development and 
survival of early neurons. Our results confirmed earlier 
reports of PFOA cytotoxicity, epigenetic toxicity, and its 
effects on gene expression and pointed to the mechanisms 
behind them. The most prominent outcomes of PFOA 
treatment on mHypoE-N46 cells were a dose dependent 
drop in cell viability, changes in the expression of some 
genes related to cell cycle, proliferation, and NGFs, and the 
activation of apoptosis-related genes. There was a dose-
dependent increase in global DNA methylation, and a 
change in the expression of the Tet and Dnmt genes. The 
expression of the Mecp2s gene, an important reader of DNA 
methylation, was reduced.
One of the most important findings of this study is the 
low PFOA IC50 value (27.52 µmol/L), which clearly 
suggests that embryonic hypothalamic cells are more 
sensitive to PFOA toxicity than other tissue cells. In 
previous studies (24, 25, 31, 32), the PFOA IC50 in other 
cell types was mostly above 200 µmol/L.
Among different genes involved in the neuronal 
apoptosis mechanism, here we focused on Bax, Casp3 and 
Trp73 genes. Bax acts as a pro-apoptotic regulator (33). 
Inactivation of Casp3 causes a delay in neuronal apoptosis 
(34), while activation of Trp73 has been implicated in 
apoptosis induced by abnormal cell proliferation and DNA 
damage (35, 36). We found that exposure to PFOA 
significantly increased the Bax gene expression in 
embryonic hypothalamus cells in a dose-dependent manner, 
Figure 3 Expression of (A) ligand (Ngf) and receptor (Ntrk1) genes of the NGF-NTRK1 neurotrophin system and (B) ligand (Bdnf) 
and receptor (Ntrk2) genes of the BDNF-NTRK2 neurotrophin system after 24 h of exposure to PFOA (PCR). Data are shown as mean 
± standard error of three independent measurements. * p<0.05, ** p<0.01, and *** p<0.001 compared to control
Figure 4 Epigenetic toxicity of PFOA: (A) relative global methylation levels; (B) relative expression of ten-eleven translocation 
methylcytosine dioxygenase-encoding Tet1, Tet2, and Tet3; (C) relative expression of DNA methyltransferase-encoding Dnmt1, Dnmt3a, 
and Dnmt3b, and (D) relative expression of methyl-CpG binding protein 2 genes. Data are shown as mean ± standard error of three 
independent measurements. * p<0.05, ** p<0.01, and *** p<0.001 compared to control
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while the expression of Casp3 and Trp73 genes significantly 
decreased. This decrease in the expression of Casp3 and 
Trp73 was consistent with the reports for bisphenol A, 
another EDC that interferes with developmental processes 
in the foetal brain (37). Our results confirmed Casp3 and 
Trp73-mediated mechanism of PFOA inhibiting apoptosis 
in embryonic hypothalamus cells, which was consistent 
with BPA. However, the finding that PFOA led to a dose-
dependent increase in the Bax gene expression, suggests 
that Bax-mediated mechanism of apoptosis prevails, despite 
the delay and suppression mechanisms mediated by Casp3 
and Trp73.
We were also interested in how PFOA affects the cell 
cycle. We already know that CCNA2 regulates cell cycle 
progression by interacting with CDK during both the G1/S 
and G2/M transition phases (38). CCNB1 and CCNE1 are 
essential for the G2/M and G1/S transition, respectively 
(39, 40). Previous studies have shown that exposure to 
PFOA alters the expression of cyclin-related genes in the 
human hepatoma cell line (HepG2) and human primary 
hepatocytes cells (41). With PFOA exposure, such a change 
in cyclin encoding gene may point to the disturbance in the 
cell cycle. CDKN1A regulates cell proliferation indirectly 
at the transcriptional level (42–44) or directly through 
proliferating cell nuclear antigen (45) and binding to CDKs 
(46, 47). Our results showed that the expression of Cdkn1a 
significantly increased in all PFOA-treated groups. 
Overexpression of p21/CDKN1A can inhibit cell 
proliferation (48) and may be involved in apoptosis (49, 
50). Overall, since there was no clear association between 
PFOA exposure and decreased cell viability, it is likely that 
the change in the expression of the cell homeostasis gene 
impaired cell viability.
Our study also focused on the neurotrophins, which are 
important for the survival, development, and function of 
neurons (51, 52), while in embryonic neurons they can 
regulate apoptosis (53, 54). We analysed relative changes 
in the expression of Ngf, Ntrk1, Bdnf, and Ntrk2 and found 
that PFOA exposure affected the BDNF-NTRK2 
neurotrophin system, as the expression levels of both the 
ligand Bdnf and the receptor Ntrk2 gene significantly 
increased. In related studies (37, 55), exposure to BPA 
altered the expression of Ngf and Bdnf genes, but not of 
Ntrk1 and Ntrk2. This suggests that changes in ligands of 
both neurotrophin systems caused by PFOA may follow a 
mechanism similar to that of BPA. On the other hand, the 
change in the expression of Ntrk2 suggests that PFOA 
disrupts the neurotrophin system through a specific 
mechanism, different from that of BPA. Additionally, these 
neurotrophin systems can interact with each other to 
regulate cell survival and death (53). We, therefore, believe 
that changes in the neurotrophin system caused by PFOA 
may affect not only growth and development but also 
survival of embryonic hypothalamic cells.
Our findings have also confirmed that PFOA increases 
overall DNA methylation in embryonic hypothalamic cells 
in a dose-dependent manner, unlike previous studies 
showing reduced global DNA methylation in PFOA-treated 
HepG2 and human breast epithelial cells (MCF7) (25, 31). 
This can be explained by the reported differences in the 
patterns of gene expression and epigenetic changes between 
tissues and cells (56, 57).
To evaluate the initiators of the changes in the patterns 
of DNA methylation after PFOA treatment we focused on 
Tets (mouse homologue of human TETs) and Dnmts (mouse 
homologue of human DNMTs). Dnmts and Tet2 expression 
decreased, while Tet1 and Tet3 expression and global DNA 
methylation increased. This points to a correlation between 
the level of PFOA exposure and the expression of cell 
homeostasis and nerve growth factor genes, and suggests 
that PFOA-induced epigenetic changes may play an 
important role in altering cell homeostasis and expression 
of neuronal growth factor genes.
Our findings of significantly downregulated expression 
of Mecp2_e1 and Mecp2_e2 genes may have wide 
ramifications, as MeCP2 not only aids in transcriptional 
silencing and acts as long-range regulator of methylated 
genes (58) but it also affects the expression of thousands 
of genes in the hypothalamus (59).
CONCLUSION
Overall, our findings suggest that exposure to PFOA 
affects cell survival through the reprogramming of 
embryonic hypothalamic DNA methylation patterns and 
altering cell homeostasis genes. They also suggest that DNA 
methylation and Mecp2 gene expression changes induced 
by PFOA could alter genes of other major mechanisms of 
the embryonic hypothalamus. All this may serve as a good 
starting point for further research into the mechanisms of 
PFOA effects on hypothalamic development.
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Epigenetska toksičnost i citotoksičnost perfluorooktanske kiseline i njezino djelovanje na gensku ekspresiju u 
stanicama hipotalamusa mišjeg embrija
Premda je perfluorooktanska kiselina (PFOA) dobro znana kao endokrini disruptor, i dalje se malo zna o mehanizmima 
u pozadini njezina djelovanja na stanice i njezine toksičnosti u kritičnoj fazi razvoja hipotalamusa. Stoga smo istražili 
njezino djelovanje u staničnoj liniji N46 hipotalamusa mišjeg embrija (mHypoE-N46) da bismo saznali o mehanizmima 
kroz koje ih PFOA oštećuje. S tom smo svrhom analizirali vijabilnost stanica, globalnu metilaciju DNA i gensku ekspresiju 
izloženih stanica. Porastom koncentracija PFOA padala je stanična vijabilnost, a globalna DNA metilacija rasla. Usto je 
PFOA značajno utjecala na ekspresiju gena povezanih s apoptozom i staničnim ciklusom, neurotrofnih gena te Tet, Dnmt 
i Mecp2 gena. Naše istraživanje ukazuje na to da izloženost PFOA utječe na preživljenje stanica hipotalamusa mišjeg 
embrija reprogramiranjem obrazaca metilacije DNA te promjenama u genima zaduženim za održavanje homeostaze. 
Metilacija DNA i promjene u ekspresiji Mecp2 gena izazvane djelovanjem PFOA također imaju široki spektar implikacija, 
budući da utječu na promjene u genima zaduženim za druge važne mehanizme u embrijskom hipotalamusu. Stoga naše 
istraživanje može poslužiti kao dobra polazna točka za daljnje istraživanje mehanizama djelovanja PFOA na razvoj 
hipotalamusa.
KLJUČNE RIJEČI: citotoksičnost; DNA metilacija; endokrini disruptori; epigenetska toksičnost; mHypoE-N46 stanična 
linija; PFOA
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